imiquimod has been researched along with Candidiasis, Chronic Mucocutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, A; Fernandes, A; Machado, S; Reis, J; van de Veerdonk, FL | 1 |
1 other study(ies) available for imiquimod and Candidiasis, Chronic Mucocutaneous
| Article | Year |
|---|---|
The potential role for topical imiquimod in the treatment of chronic mucocutaneous candidiasis caused by gain-of-function mutation in STAT1: A case-report.
Topics: Candidiasis, Chronic Mucocutaneous; Gain of Function Mutation; Humans; Imiquimod; Mutation; STAT1 Transcription Factor | 2021 |